Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study.

Crisafulli A, Marini H, Bitto A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, D'Anna R, Corrado F, Bartolone S, Frisina N, Squadrito F.

Menopause. 2004 Jul-Aug;11(4):400-4.

PMID:
15243277
2.

Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.

D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Adamo EB, Squadrito F.

Menopause. 2009 Mar-Apr;16(2):301-6. doi: 10.1097/gme.0b013e318186d7e2.

PMID:
19034051
3.

Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.

D'Anna R, Cannata ML, Atteritano M, Cancellieri F, Corrado F, Baviera G, Triolo O, Antico F, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Marini H, Squadrito F.

Menopause. 2007 Jul-Aug;14(4):648-55.

PMID:
17251874
4.

Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.

Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.

J Bone Miner Res. 2002 Oct;17(10):1904-12.

5.

Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.

Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N, D'Anna R, Corrado F, Ruggeri P, Frisina N, Squadrito G.

Am J Med. 2003 Apr 15;114(6):470-6.

PMID:
12727580
6.

The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.

Kroiss R, Fentiman IS, Helmond FA, Rymer J, Foidart JM, Bundred N, Mol-Arts M, Kubista E.

BJOG. 2005 Feb;112(2):228-33.

7.

Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.

Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.

Am J Obstet Gynecol. 2004 Dec;191(6):1979-88.

PMID:
15592280
8.

Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.

Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R.

Maturitas. 2007 Nov 20;58(3):249-58. Epub 2007 Oct 29.

PMID:
17913408
9.

Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women.

Crisafulli A, Altavilla D, Marini H, Bitto A, Cucinotta D, Frisina N, Corrado F, D'Anna R, Squadrito G, Adamo EB, Marini R, Romeo A, Cancellieri F, Buemi M, Squadrito F.

Menopause. 2005 Mar;12(2):186-92.

PMID:
15772566
10.

Effect of pure genistein on bone markers and hot flushes.

Albertazzi P, Steel SA, Bottazzi M.

Climacteric. 2005 Dec;8(4):371-9.

PMID:
16390772
11.
12.

Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.

Rowan JP, Simon JA, Speroff L, Ellman H.

Clin Ther. 2006 Jun;28(6):921-32. Erratum in: Clin Ther. 2006 Aug;28(8):1244.

PMID:
16860174
13.

A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.

Benster B, Carey A, Wadsworth F, Vashisht A, Domoney C, Studd J.

Menopause Int. 2009 Jun;15(2):63-9. doi: 10.1258/mi.2009.009014.

PMID:
19465671
14.

A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium.

Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM.

J Soc Gynecol Investig. 2002 Jul-Aug;9(4):238-42.

PMID:
12113884
15.

Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.

Archer DF; EstroGel Study Group.

Menopause. 2003 Nov-Dec;10(6):516-21.

PMID:
14627859
17.

Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.

Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L Jr.

Obstet Gynecol. 2004 Feb;103(2):267-73.

PMID:
14754694
19.

Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.

Palacios S, Farias ML, Luebbert H, Gomez G, Yabur JA, Quail DC, Turbi C, Kayath MJ, Almeida MJ, Mönnig E, Nickelsen T.

Am J Obstet Gynecol. 2004 Jul;191(1):121-31.

PMID:
15295352
20.

Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.

Archer DF, Thorneycroft IH, Foegh M, Hanes V, Glant MD, Bitterman P, Kempson RL.

Menopause. 2005 Nov-Dec;12(6):716-27. Epub 2005 Nov 8.

PMID:
16278615
Items per page

Supplemental Content

Write to the Help Desk